טוען...
Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
BACKGROUND: Carmustine (BCNU) wafers (Gliadel) prolongs local disease control and progression-free survival (PFS) in patients with malignant gliomas. However, in metastatic brain tumors, there is a paucity of evidence in support of its safety and efficacy. The goal of this study was to assess the sa...
שמור ב:
| הוצא לאור ב: | Surg Neurol Int |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4866053/ https://ncbi.nlm.nih.gov/pubmed/27217968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2152-7806.181987 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|